top of page

We are pioneers in zinc research for brain injury and neurodegenerative disease.


  • The company established in 2020.03

  • lCurrent Investment: 1.5 M USD from Venture Capitals

  • ​Research : Acute Brain Injury, Neurodegenerative disease

  • Government Funded Research Projects

    • TIPS​(Tech Incubator Program for Startup)

      • Multiple Sclerosis (Lead compound)

      • Grant 0.4M USD 2021.7~2023.6​

    • KDDF​(Korea Drug Development Fund)

      • Amyotrophic Lateral Sclerosis(Preclinical candidate)​

      • Grant: 1M USD 2023.4~2025.3

  • Collaboration with Asan Medical Center, Hallym University, and Harvard Medical School

제목 없음.png
bottom of page